Nabriva Therapeutics plc (NBRV)’in fiyatı nedir?

Nabriva Therapeutics plc (NBRV)’in fiyatı $0.63’dir

Nabriva Therapeutics plc (NBRV)’in piyasa değeri nedir?

Nabriva Therapeutics plc (NBRV)’in piyasa değeri $284.20K’dir.

Nabriva Therapeutics plc (NBRV) Hisse Bölünmeleri

Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.

Yıl	Bölünme	Çarpan	Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.

Yıl

Bölünme

Çarpan

Kümülatif Çarpan

Sağlanan tarihler için yeterli veri yok.

Şirket	Hisse bölünme sayısı	Kümülatif Çarpan	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Şirket

Hisse bölünme sayısı

Kümülatif Çarpan

Ülke